Effect of Single-Clove Garlic (Allium Sativum Var. Solo Garlic) Extract on Lipid Profile in Male Wistar Rats with Dyslipidemia”
DOI:
https://doi.org/10.37287/ijghr.v8i2.889Keywords:
dyslipidemia, garlic, lipids, plant extracts, wistar ratsAbstract
Dyslipidemia, a major risk factor for cardiovascular diseases, is characterized by abnormal lipid profiles. While conventional treatments exist, they often have side effects, leading to a growing interest in natural alternatives. Single-clove garlic (Allium sativum var. solo) contains bioactive compounds known for their antioxidant and lipid-lowering properties. This study aimed to evaluate the effectiveness of single-clove garlic extract in improving the lipid profile, including total cholesterol, triglycerides, HDL, and LDL, in dyslipidemic male Wistar rats. A quasi-experimental pre-test and post-test control group design was used with 24 male Wistar rats using purposive sampling. Dyslipidemia was induced with a high-fat diet for 40 days. The rats were divided into four groups: a positive control (simvastatin), a negative control, and two treatment groups receiving different doses of single-clove garlic extract. Lipid profiles were measured on days 7, 14, 21, and 28. Data were analyzed using one-way ANOVA and Tukey’s HSD post-hoc test. The administration of single-clove garlic extract significantly improved the lipid profile of the rats. Over 28 days, treatment groups showed a significant reduction in total cholesterol, triglycerides, and LDL levels, while HDL levels increased. These changes were comparable to those observed in the positive control group. The findings suggest that single-clove garlic extract is effective in improving the lipid profile in dyslipidemic male Wistar rats.
References
Agung, L. R. (2021). Pengaruh Daun Salam (Syzygium polyanthum) Terhadap Kadar Trigliserida Dan Kolesterol Total Darah Pada Penderita Dislipidemia. Jurnal Ilmiah Kesehatan Sandi Husada, 10(2), 408–412. https://doi.org/10.35816/jiskh.v10i2.617
Ahmad, Robert & Atiku. (2024). Effect of Garlic (Allium Sativum) Extract on Serum Lipid Profile of Atorvastatin Induced Dyslipidaemic Albino Rats Fed with High Fat Diet (HFD). Bayero Journal of Pure and Applied Sciences, 17(1), 39–42.
Berberich, A. J. & Hegele, R. A. (2022). A Modern Approach to Dyslipidemia. Endocrine Reviews, 43(4), 611–653. https://doi.org/10.1210/endrev/bnab037
Clayton, M. K. & Federer, W. T. (1999). Statistical Design and Analysis for Intercropping Experiments. Vol. II: Three or More Crops. In Journal of the American Statistical Association (Vol. 94, Issue 448). https://doi.org/10.2307/2669950
Finney, A. C., Das, S., Kumar, D., McKinney, M. P., Cai, B., Yurdagul, A. & Rom, O. (2023). The interplay between nonalcoholic fatty liver disease and atherosclerotic cardiovascular disease. Frontiers in Cardiovascular Medicine, 10(May), 1–28. https://doi.org/10.3389/fcvm.2023.1116861
Gebhardt, R. (1993). Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes. Lipids, 28(7), 613–619. https://doi.org/10.1007/BF02536055
Juniar;, D. A., Rahayuning;, D. & Rahfilidun;, Z. (2019). Faktor-Faktor Yang Berhubungan Dengan Status Gizi Bayi Usia 0-6 Bulan (Studi Kasus Di Wilayah Kerja Puskesmas Gebang, Kecamatan Gebang, Kabupaten Purworejo). Jurnal Kesehatan Masyarakat (e-Journal), 7(1), 289–296.
Kong, F., Ding, Z., Zhang, K., Duan, W., Qin, Y., Su, Z. & Bi, Y. (2020). Optimization of extraction flavonoids from Exocarpium Citri Grandis and evaluation its hypoglycemic and hypolipidemic activities. Journal of Ethnopharmacology, 262(June), 113178. https://doi.org/10.1016/j.jep.2020.113178
Młynarska, E., Hajdys, J., Czarnik, W., Fularski, P., Leszto, K., Majchrowicz, G., Lisińska, W., Rysz, J. & Franczyk, B. (2024). The Role of Antioxidants in the Therapy of Cardiovascular Diseases—A Literature Review. Nutrients, 16(16), 1–26. https://doi.org/10.3390/nu16162587
Mohammed Basheeruddin Asdaq, S., Yasmin, F., Alsalman, A. J., Al mohaini, M., Kamal, M., Al Hawaj, M. A., Alsalman, K. J., Imran, M. & Sreeharsha, N. (2022). Obviation of dyslipidemia by garlic oil and its organosulfur compound, diallyl disulphide, in experimental animals. Saudi Journal of Biological Sciences, 29(4), 2520–2525. https://doi.org/10.1016/j.sjbs.2021.12.025
Najman, K., Leontowicz, H. & Leontowicz, M. (2021). The influence of plants from the alliaceae family on morphological parameters of the intestine in atherogenic rats. Nutrients, 13(11), 1–24. https://doi.org/10.3390/nu13113876
Powell-Wiley, T. M., Poirier, P., Burke, L. E., Després, J. P., Gordon-Larsen, P., Lavie, C. J., Lear, S. A., Ndumele, C. E., Neeland, I. J., Sanders, P. & St-Onge, M. P. (2021). Obesity and Cardiovascular Disease A Scientific Statement From the American Heart Association. Circulation, 143(21), E984–E1010. https://doi.org/10.1161/CIR.0000000000000973
Qoyimmah, A. M. & Herdyastuti, N. (2025). Identification of Bioactive Compounds in Garlic (Allium sativum L.) with Hypocholesterolemic Potential. Jurnal Pijar Mipa, 20(5), 802–807. https://doi.org/10.29303/jpm.v20i5.9297
Thongtang, N., Sukmawan, R., Llanes, E. J. B. & Lee, Z. V. (2022). Dyslipidemia management for primary prevention of cardiovascular events: Best in-clinic practices. Preventive Medicine Reports, 27(May), 101819. https://doi.org/10.1016/j.pmedr.2022.101819
Vögeli, B., Engilberge, S., Girard, E., Riobé, F., Maury, O., Erb, T. J., Shima, S. & Wagner, T. (2018). Archaeal acetoacetyl-CoA thiolase/HMG-CoA synthase complex channels the intermediate via a fused CoA-binding site. Proceedings of the National Academy of Sciences of the United States of America, 115(13), 3380–3385. https://doi.org/10.1073/pnas.1718649115
Zhao, D., Liu, J., Wang, M., Zhang, X. & Zhou, M. (2019). Epidemiology of cardiovascular disease in China: current features and implications. Nature Reviews Cardiology, 16(4), 203–212. https://doi.org/10.1038/s41569-018-0119-4
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Indonesian Journal of Global Health Research
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
